The Mono Pharmacare IPO commenced on August 28, 2023, and concluded on August 30, 2023. The allotment of shares took place on September 4, 2023, and the initiation of refunds began on September 5, 2023. The shares were credited to the demat accounts of investors on September 6, 2023. Finally, the listing of Mono Pharmacare on the stock exchange occurred on September 7, 2023.
The Mono Pharmacare IPO was priced at ₹26 to ₹28 per share, with a lot size of 4000. The total issue size was ₹14.84 crores, comprising a fresh issue of ₹14.84 crores. The IPO was listed on both the NSE SME.
In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 10% of the shares, the NII (Non-Institutional Investors) quota was reserved for 45% of the shares, and the retail quota was reserved for 45% of the shares.
Mono Pharmacare IPO Basic Details
| Company Name | Mono Pharmacare Limited |
| Domain of Company | Marketing and distribution of pharmaceutical products |
| Mono Pharmacare IPO GMP Today | ₹4 |
| Mono Pharmacare IPO Listing Gain | 14.29% |
| Mono Pharmacare IPO Open Date | August 28, 2023 |
| Mono Pharmacare IPO Close Date | August 30, 2023 |
| Mono Pharmacare IPO Allotment Date | September 4, 2023 |
| Mono Pharmacare IPO Listing Date | September 7, 2023 |
| Face Value | ₹10 per share |
| Price | ₹26 to ₹28 per share |
| Lot Size | 4000 Shares |
| Issue Size | 5,300,000 shares of ₹10 (aggregating up to ₹14.84 Cr) |
| Fresh Issue | 5,300,000 shares of ₹10 (aggregating up to ₹14.84 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Company Promoters | Panilam Lakhatariya And Supal Lakhatariya |
Mono Pharmacare IPO GMP Today:
| Date | GMP | Listing Gain | Kostak | Subject to |
| 6 September 2023 | ₹4 | 14.29% | – | – |
| 5 September 2023 | ₹3 | 10.71% | – | – |
| 4 September 2023 | ₹3 | 10.71% | – | – |
| 3 September 2023 | ₹3 | 10.71% | – | – |
| 2 September 2023 | ₹3 | 10.71% | – | – |
| 1 September 2023 | ₹3 | 10.71% | – | – |
| 31 August 2023 | ₹3 | 10.71% | – | – |
| 30 August 2023 | ₹0 | 0.00% | – | – |
| 29 August 2023 | ₹0 | 0.00% | – | – |
| 28 August 2023 | ₹0 | 0.00% | – | – |
| 27 August 2023 | ₹0 | 0.00% | – | – |
| 26 August 2023 | ₹0 | 0.00% | – | – |
Mono Pharmacare IPO Details:
Established in 1994, Mono Pharmacare Limited is involved in the pharmaceutical product marketing and distribution business. The company offers a wide range of products, including healthcare items, antibiotics, cough and cold remedies, antifungal medications, nutraceuticals, pain relievers, antacids, antiemetics, cardiac-diabetic medicines, and cosmocare products.
To expand its product line in specific therapeutic areas, Mono Pharmacare collaborates with contract manufacturers to produce pharmaceutical products sold under its DLS Export brand name. In 2022, the company acquired DLS Export for ₹609 lakhs.
As of February 28, 2023, Mono Pharmacare has partnered with 168 pharmaceutical companies as distributors and stockists. Additionally, the company has served more than 3,036 customers and vendors, consisting of both retail pharmacy stores and wholesalers.
Mono Pharmacare IPO More Details Click Here
Mono Pharmacare IPO FAQs
When is Mono Pharmacare IPO open?
Mono Pharmacare IPO will open on 28 August 2023.
When is Mono Pharmacare IPO Close?
Mono Pharmacare IPO will be closed on 30 August 2023.
What is Mono Pharmacare IPO GMP Today?
The Mono Pharmacare IPO GMP aka Grey Market Premium is ₹4.
What is Mono Pharmacare IPO Kostak Rates Today?
The Mono Pharmacare IPO Kostak Rate is ₹000.
What is Mono Pharmacare IPO Subject to Sauda Price Today?
The Mono Pharmacare IPO subject to sauda rates is ₹000.
Mono Pharmacare IPO Expected Returns?
The Mono Pharmacare expected return is 14.29%.
How much will be the listing gain in Mono Pharmacare IPO?
Mono Pharmacare IPO will get listing gain of 14.29%. (Approx.)
